{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:48:20Z","timestamp":1772120900258,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0565.07"],"award-info":[{"award-number":["G0565.07"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G0686.09"],"award-info":[{"award-number":["G0686.09"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.0172.03"],"award-info":[{"award-number":["G.0172.03"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["G.149.03"],"award-info":[{"award-number":["G.149.03"]}],"id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","award":["EF\/95\/010"],"award-info":[{"award-number":["EF\/95\/010"]}],"id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.eururo.2013.05.031","type":"journal-article","created":{"date-parts":[[2013,5,18]],"date-time":"2013-05-18T17:28:16Z","timestamp":1368898096000},"page":"502-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Chronic Administration of Anticholinergics in Rats Induces a Shift from Muscarinic to Purinergic Transmission in the Bladder Wall"],"prefix":"10.1016","volume":"64","author":[{"given":"Pieter","family":"Uvin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathieu","family":"Boudes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aur\u00e9lie","family":"Menigoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Franken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00edlvia","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Gevaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Verplaetse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Tytgat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rudi","family":"Vennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Voets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"De Ridder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2013.05.031_bib0005","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2008.08036.x","article-title":"The economic impact of overactive bladder syndrome in six Western countries","volume":"103","author":"Irwin","year":"2009","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.031_bib0010","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","article-title":"Muscarinic receptor antagonists for overactive bladder","volume":"100","author":"Abrams","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.031_bib0015","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1097\/01.ju.0000049903.60057.4b","article-title":"Intravesical oxybutynin: a local anesthetic effect on bladder C afferents","volume":"169","author":"De Wachter","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0020","first-page":"728","article-title":"Comparing adherence and persistence across 6 chronic medication classes","volume":"15","author":"Yeaw","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.eururo.2013.05.031_bib0025","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/j.juro.2009.11.026","article-title":"Overactive bladder medication adherence when medication is free to patients","volume":"183","author":"Sears","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0030","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-157-8-201210160-02004","article-title":"ACP Journal Club. Review: drugs for urgency urinary incontinence improve continence in women","volume":"157","author":"Dmochowski","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.eururo.2013.05.031_bib0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1124\/pr.56.4.4","article-title":"Pharmacology of the lower urinary tract: basis for current and future treatments of urinary incontinence","volume":"56","author":"Andersson","year":"2004","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.eururo.2013.05.031_bib0040","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0014-2999(82)90330-2","article-title":"The use of the slowly degradable analog, alpha, beta-methylene ATP, to produce desensitisation of the P2-purinoceptor: effect on non-adrenergic, non-cholinergic responses of the guinea-pig urinary bladder","volume":"86","author":"Kasakov","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0045","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1016\/S0022-5347(05)67618-5","article-title":"Distribution of P2X receptors in the urinary bladder and the ureter of the rat","volume":"163","author":"Lee","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0050","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0024-3205(94)00909-0","article-title":"Purinergic and cholinergic components of bladder contractility and flow","volume":"56","author":"Theobald","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.eururo.2013.05.031_bib0055","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1113\/jphysiol.1984.sp015386","article-title":"A comparison of spontaneous and nerve-mediated activity in bladder muscle from man, pig and rabbit","volume":"354","author":"Sibley","year":"1984","journal-title":"J Physiol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0060","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/nau.21108","article-title":"Rodent models for urodynamic investigation","volume":"30","author":"Andersson","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2013.05.031_bib0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.urology.2008.04.038","article-title":"Effect of long-term oxybutynin administration on c-Fos expression in spinal neurons: inhibition of antimuscarinics on bladder afferents in conscious rats","volume":"73","author":"Haga","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.eururo.2013.05.031_bib0070","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/nau.21180","article-title":"Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice","volume":"30","author":"Boudes","year":"2011","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2013.05.031_bib0075","first-page":"e3869","article-title":"The use of cystometry in small rodents: a study of bladder chemosensation","author":"Uvin","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.eururo.2013.05.031_bib0080","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1074\/jbc.275.16.11934","article-title":"Assembly of Trp1 in a signaling complex associated with caveolin-scaffolding lipid raft domains","volume":"275","author":"Lockwich","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.eururo.2013.05.031_bib0085","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1172\/JCI31766","article-title":"Deletion of the transient receptor potential cation channel TRPV4 impairs murine bladder voiding","volume":"117","author":"Gevaert","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.eururo.2013.05.031_bib0090","doi-asserted-by":"crossref","first-page":"F692","DOI":"10.1152\/ajprenal.00599.2009","article-title":"Functional characterization of transient receptor potential channels in mouse urothelial cells","volume":"298","author":"Everaerts","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0095","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/S0022-5347(05)68247-X","article-title":"A quantitative study of atropine-resistant contractile responses in human detrusor smooth muscle, from stable, unstable and obstructed bladders","volume":"162","author":"Bayliss","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0100","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1139\/y83-182","article-title":"Human female bladder and its noncholinergic contractile function","volume":"61","author":"Cowan","year":"1983","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0105","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/S0022-5347(17)53509-0","article-title":"Atropine resistance of transmurally stimulated isolated human bladder muscle","volume":"128","author":"Sj\u00f6gren","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0110","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1464-410X.1987.tb05031.x","article-title":"Pathophysiology of idiopathic detrusor instability and detrusor hyper-reflexia. An in vitro study of human detrusor muscle","volume":"60","author":"Kinder","year":"1987","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0115","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1464-410X.2004.05058.x","article-title":"Transmitters contributing to the voiding contraction in female rats","volume":"94","author":"Streng","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.031_bib0120","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/MOU.0b013e32832ce8a4","article-title":"Pharmacological treatment of overactive bladder: report from the International Consultation on Incontinence","volume":"19","author":"Andersson","year":"2009","journal-title":"Curr Opin Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0125","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1002\/nau.20208","article-title":"Systemic oxybutynin decreases afferent activity of the pelvic nerve of the rat: new insights into the working mechanism of antimuscarinics","volume":"25","author":"De Laet","year":"2006","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.eururo.2013.05.031_bib0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2165\/00002512-199506030-00007","article-title":"Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability","volume":"6","author":"Yarker","year":"1995","journal-title":"Drugs Aging"},{"key":"10.1016\/j.eururo.2013.05.031_bib0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0022-5347(05)65403-1","article-title":"P2X receptors and their role in female idiopathic detrusor instability","volume":"167","author":"O\u2019Reilly","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2013.05.031_bib0140","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1464-410X.2006.06010.x","article-title":"Alterations in purinergic and cholinergic components of contractile responses of isolated detrusor contraction in a rat model of partial bladder outlet obstruction","volume":"97","author":"Banks","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.eururo.2013.05.031_bib0145","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1159\/000209255","article-title":"Muscarinic receptor subtypes in the lower urinary tract","volume":"83","author":"Giglio","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.eururo.2013.05.031_bib0150","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.brainresbull.2008.07.011","article-title":"Activation of cholinergic receptors blocks non-adrenergic non-cholinergic contractions in the rat urinary bladder","volume":"77","author":"Lai","year":"2008","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.eururo.2013.05.031_bib0155","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-2999(01)01286-9","article-title":"On the functional role of muscarinic M2 receptors in cholinergic and purinergic responses in the rat urinary bladder","volume":"428","author":"Giglio","year":"2001","journal-title":"Eur J Pharmacol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813004971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283813004971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:02:56Z","timestamp":1759582976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283813004971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S0302283813004971"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2013.05.031","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718030157.793480180","asserted-by":"object"}]},"ISSN":["0302-2838"],"issn-type":[{"value":"0302-2838","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic Administration of Anticholinergics in Rats Induces a Shift from Muscarinic to Purinergic Transmission in the Bladder Wall","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2013.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}